New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.
Patients want options, or choice, when it comes to clinical trial participation. New data from a recent Study Voices survey reveals the impact choice can have on participation. The findings empower clinical trial sponsors to shift from traditional clinical trial enrollment models to hybrid enrollment models.
Topics: Most Viewed, Study Voices, Aaron Fleishman, International Clinical Trials, Surveys, Hybrid Clinical Trials
New survey results and insights help clinical trial sponsors improve diversity and inclusion, enroll faster, and keep participants engaged longer.
When we developed our latest Study Voices survey, we expected to see large gaps in attitudes and experiences among healthcare consumers and clinical trial participants based on factors such as age, race, ethnicity, gender, and income – but that wasn’t the case.
Topics: Patient Engagement, Study Voices, Surveys, Diversity, Inclusion, Patients, Hybrid Clinical Trials, Whitepaper
Each year members of the industry gather together at Dpharm — a conference which challenges attendees to question how we, as an industry, can disrupt clinical research to reduce the burden to patients and physicians. This year's event will be held virtually September 28-29 and will focuses on making innovation stick in a post-COVID world.
Topics: Disruptive Innovation, Conferences, Study Voices, DPHARM, Surveys, Danielle Frate, Alexia Medici, Decentralized Clinical Trials
Clinical Trial Innovation: More Important Now Than Ever
A new survey gives voice to the healthcare consumer in the wake of COVID-19 and highlights the importance of innovation in clinical trial patient enrollment and engagement.
New data provides clinical trial sponsors with the information they need to confidently embrace innovative solutions in response to COVID-19. The Study Voices 2020* survey reflects perspectives from patients, medical professionals, and members of the pharmaceutical industry. The findings reveal shifts in attitudes and behaviors since the onset of COVID-19 – insight that clinical trial sponsors can leverage for enrollment and engagement efforts, including for hybrid and virtual study models.
Topics: Patient Engagement, Patient Experience, Healthcare Consumer, COVID-19, International Clinical Trials, Patient Voice, Telehealth, Elizabeth Gargill, Study Voices 2020, Surveys, Site Voice, Publications